மதிப்பெண்கள் ஶீர்மந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மதிப்பெண்கள் ஶீர்மந். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மதிப்பெண்கள் ஶீர்மந் Today - Breaking & Trending Today

Editas Medicine Announces First Quarter 2021 Results and


Advancing BRILLIANCE trial of EDIT-101 for LCA10; clinical data expected by year-end
RUBY trial of EDIT-301 for sickle cell disease active and recruiting
Preclinical ocular data presented at ARVO supports in vivo
gene editing
$723 million
as of March 31, 2021
CAMBRIDGE, Mass., May 05, 2021 (GLOBE NEWSWIRE) Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today reported business highlights and financial results for the first quarter of 2021.
“Our team is making tremendous progress towards discovering, developing, and manufacturing novel genome editing medicines, including excellent forward momentum this quarter for our two clinical-stage medicines,” said James C. Mullen, Chairman, President and Chief Executive Officer, Editas Medicine. “We are pleased to announce Dr. Mark Shearman will be joining Editas as Chief Scientific Officer in June 2021. Mark has an outstanding track record of drug discovery and development, an ....

City Of , United Kingdom , United States , Marks Shearman , Mark Shearman , Jamesc Mullen , Research Early Development , European Hematology Association , Merck Co , Merck Kga , Serono Inc , World Medical Innovation Forum , Virtual Congress , Bristol Myers Squibb , University Of Bristol , Genetic Technologies Corporation , Raymond James Human Health Innovation Conference , University Of Nottingham , American Association For Cancer Research , Research Laboratories , Merck Kgaa , Editas Medicine Inc , Association For Research , Strengthening Leadership , Adding Mark , Chief Scientific ,